Safety and Preliminary Activity of BI115 in Advanced SCLC

Clinical trial NCT07559019 · RECRUITING

Trial details

NCT number: NCT07559019
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer (SCLC)

Start date: 2026-05-21
Primary completion: 2028-02-29
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.